FDA moves to undercut huge price increase by pregnancy drug maker

Plain Dealer (McClatchy-Tribune News Service)
WASHINGTON -- The Food and Drug Administration took the unusual step Wednesday of inviting pharmacies to make a legal end run around a St. Louis company that obtained agency approval for a pregnancy drug and promptly raised the price from $20 per dose to $1,500.
The drug, a synthetic form of progesterone trade named Makena, is recommended for women at high risk of delivering prematurely. And the price increase K-V Pharmaceutical Co. ignited a firestorm of objections from patients, medical organizations and political leaders including Sen. Sherrod Brown of Ohio.
To read the rest of the article, click on the source link above.

WASHINGTON -- The Food and Drug Administration took the unusual step Wednesday of inviting pharmacies to make a legal end run around a St. Louis company that obtained agency approval for a pregnancy drug and promptly raised the price from $20 per dose to $1,500.

The drug, a synthetic form of progesterone trade named Makena, is recommended for women at high risk of delivering prematurely. And the price increase K-V Pharmaceutical Co. ignited a firestorm of objections from patients, medical organizations and political leaders including Sen. Sherrod Brown of Ohio.

To read the rest of the article, click on the source link above.

FDA moves to undercut huge price increase by pregnancy drug maker »